Affordable Access

[Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity].

Authors
  • Javier Manchón, G
  • Natal Pujol, A
  • Coroleu Lletget, W
  • Zuasnábar Cotro, A
  • Badía Barnusell, J
  • Juncá Piera, J
  • Bel Comós, J
  • Sábado Alvarez, C
  • Prats Viñas, J
Type
Published Article
Journal
Anales españoles de pediatría
Publication Date
Jun 01, 1997
Volume
46
Issue
6
Pages
587–592
Identifiers
PMID: 9297428
Source
Medline
License
Unknown

Abstract

We have been able to find 11 controlled studies in the medical literature which deal with the clinical usage of rH-EPO in newborns. Six use the hormone in an early phase and 5 in a posterior one. Our study should be included in the later and, as happens in most of them, demonstrates the efficacy of rH-EPO in the treatment of late anemia of the preterm newborn as shown by an increment in the hemoglobin levels and a trend towards the diminution in the use of blood transfusions. We have not observed substantial adverse effects.

Report this publication

Statistics

Seen <100 times